Progressive disease in glioblastoma: Benefits and limitations of semi-automated volumetry.

Progressive disease in glioblastoma: Benefits and limitations of semi-automated volumetry.

PURPOSE:Unambiguous evaluation of glioblastoma (GB) progression is crucial, both for clinical trials as well as day by day routine management of GB patients. 3D-volumetry in the follow-up of GB provides quantitative data on tumor extent and growth, and therefore has the potential to facilitate objec...

Full description

Bibliographic Details
Main Authors: Thomas Huber, Georgina Alber, Stefanie Bette, Johannes Kaesmacher, Tobias Boeckh-Behrens, Jens Gempt, Florian Ringel, Hanno M Specht, Bernhard Meyer, Claus Zimmer, Benedikt Wiestler, Jan S Kirschke
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5330491?pdf=render

Internet

http://europepmc.org/articles/PMC5330491?pdf=render

Similar Items